Estonia vs Lithuania: Pharmaceutical consumption

Estonia
223.4 Defined daily dose per 1 000 inhabitants per day
in 2025
Lithuania
229 Defined daily dose per 1 000 inhabitants per day
in 2024
Estonia rank
6th
Lithuania rank
5th

Pharmaceutical consumption over time

  • Estonia
  • Lithuania
050100150200250199920122025

How they compare

Lithuania currently reports 229 Defined daily dose per 1 000 inhabitants per day against 223.4 Defined daily dose per 1 000 inhabitants per day in Estonia, a difference of 5.6 Defined daily dose per 1 000 inhabitants per day.

The two have swapped places 1 time across 15 shared years of data; in 2010 it was Estonia ahead.

Estonia ranks 6th and Lithuania ranks 5th of 7 countries.

Across the 2 decades both report, Estonia averaged higher in 1 and Lithuania in 1.

Head to head by decade

Decade Estonia Lithuania Difference Ahead
2010s 151.32 Defined daily dose per 1 000 inhabitants per day 119.34 Defined daily dose per 1 000 inhabitants per day 31.98 Defined daily dose per 1 000 inhabitants per day Estonia
2020s 194.68 Defined daily dose per 1 000 inhabitants per day 207.44 Defined daily dose per 1 000 inhabitants per day 12.76 Defined daily dose per 1 000 inhabitants per day Lithuania

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pharmaceutical consumption, Estonia or Lithuania?
Lithuania, at 229 Defined daily dose per 1 000 inhabitants per day against 223.4 Defined daily dose per 1 000 inhabitants per day in Estonia as of 2024.
What is the difference in pharmaceutical consumption between Estonia and Lithuania?
5.6 Defined daily dose per 1 000 inhabitants per day, with Lithuania ahead.
How many years of comparable data are there for Estonia and Lithuania?
15 years are reported by both, from 2010 to 2024.
How do Estonia and Lithuania rank globally for pharmaceutical consumption?
Estonia ranks 6th and Lithuania ranks 5th of 7 countries.
Where does this data come from?
Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Estonia vs Lithuania: Pharmaceutical consumption. Statizoid, drawing on Organisation for Economic Co-operation and Development. Retrieved 03 October 2026, from https://health.statizoid.com/compare/pharmaceutical-consumption/estonia-2/lithuania-2/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under OECD Terms and Conditions (attribution required); please keep the attribution.

<a href="https://health.statizoid.com/compare/pharmaceutical-consumption/estonia-2/lithuania-2/">Estonia vs Lithuania: Pharmaceutical consumption</a> — Statizoid

About this data

Indicator
Pharmaceutical consumption
Unit
Defined daily dose per 1 000 inhabitants per day
Source
Organisation for Economic Co-operation and Development
Licence
OECD Terms and Conditions (attribution required)
Coverage
31 places, 708 data points, 1980–2025
Last refreshed

Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.